Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Avant Brands Adopts Shareholder Rights Plan
Healthcare & PharmaceuticalCompany Update

Avant Brands Adopts Shareholder Rights Plan

January 9, 2026 4:30 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, announces that its board of directors (the "Board") has approved the adoption of a shareholder rights plan (the "Shareholder Rights Plan"), pursuant to a shareholder rights plan agreement entered into with Computershare Investor Services Inc., as rights agent, dated and effective January 9, 2026....

Read more
Desert Oasis Healthcare Recognized as a Fortune Best (Large) Workplace in Healthcare for Six Consecutive Years
Healthcare & PharmaceuticalAwards

Desert Oasis Healthcare Recognized as a Fortune Best (Large) Workplace in Healthcare for Six Consecutive Years

January 9, 2026 10:00 AM

Desert Oasis Healthcare (DOHC) has been recognized as one of Fortune's Best (Large) Workplaces in Healthcare for six consecutive years, from 2020 through 2025, underscoring DOHC's sustained commitment to a people-first culture and excellence in healthcare delivery. The annual Fortune Best Workplaces in Healthcare list is based on confidential employee feedback, evaluating trust, respect, fairness, pride, and camaraderie in the workplace. DOHC's...

Read more
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
Healthcare & PharmaceuticalCompany Update

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality

January 9, 2026 8:05 AM

Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology Company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced that the Company has entered into a $60 million equity line of credit (ELOC) agreement with Yorkville Advisors Global, LP, strengthening the Company's financial flexibility as it continues to advance its clinical and...

Read more
Curiteva Announces First Clinical Use of Inspire Standalone ALIF System
Healthcare & PharmaceuticalCompany Update

Curiteva Announces First Clinical Use of Inspire Standalone ALIF System

January 9, 2026 8:00 AM

Curiteva, Inc., a leading technology and manufacturing company, proudly announces the first cases using its Inspire Standalone ALIF System. This milestone completes the company's anterior launch strategy and establishes the Inspire portfolio as a comprehensive, 360-degree solution for surgeons addressing spinal pathologies. This press release follows the recent publication of a peer-reviewed study in the Journal of Biomaterials, highlighting...

Read more
LA Breast and Body Announces New Advances in Aesthetic Flat Closure Techniques
Healthcare & PharmaceuticalCompany Update

LA Breast and Body Announces New Advances in Aesthetic Flat Closure Techniques

January 9, 2026 5:00 AM

Dr. Wai-Yee Li of LA Breast and Body introduces groundbreaking insights on aesthetic flat closure, offering patients a personalized, compassionate approach to chest wall reconstruction. Dr. Wai-Yee Li, a board-certified plastic surgeon and founder of LA Breast and Body, is pioneering a personalized approach to breast surgery, with a particular focus on breast reconstruction and aesthetic flat closure procedures. These advancements challenge...

Read more
Umbrella Labs Introduces Research Use Only 5 AMINO 1MQ Liquid Program To Support High Rigor NNMT, NAD+ Salvage, And Methyl Donor Bench Science
Healthcare & PharmaceuticalCompany Update

Umbrella Labs Introduces Research Use Only 5 AMINO 1MQ Liquid Program To Support High Rigor NNMT, NAD+ Salvage, And Methyl Donor Bench Science

January 9, 2026 2:45 AM

Umbrella Labs today announced the availability of 5 AMINO 1MQ as a research use only small molecule chemical probe supported by a documentation first workflow built for laboratories that need traceable materials, consistent handling guidance, and assay aware characterization for enzyme inhibition studies. Product access for 5 AMINO 1MQ liquid in the Umbrella Labs catalog is available here:...

Read more
Nevada Donor Network Awarded Southern Florida Designated Service Area by CMS Following Competitive National Bid Process
Healthcare & PharmaceuticalCompany Update

Nevada Donor Network Awarded Southern Florida Designated Service Area by CMS Following Competitive National Bid Process

January 8, 2026 4:30 PM

Nevada Donor Network (NDN) announced today that it has been awarded the Southern Florida Designated Service Area (DSA) by the Centers for Medicare & Medicaid Services (CMS) following an extensive and highly competitive bid process initiated after the decertification of Life Alliance Organ Recovery Agency (LAORA) in September 2025. The CMS decision reflects confidence in NDN's proven ability to stabilize, rebuild, and lead high-performing organ...

Read more
Good Look: A Decade Redefining On-Demand Beauty and Building Toward Unicorn Potential
Healthcare & PharmaceuticalCompany Update

Good Look: A Decade Redefining On-Demand Beauty and Building Toward Unicorn Potential

January 8, 2026 12:30 PM

What began as a visionary idea in Mexico has evolved into one of the most ambitious international platforms in the on-demand beauty industry. As it approaches its 10th anniversary in 2026, Good Look-the makeup and hairstyling platform founded by Fer Arriaga-is entering a decisive phase marked by accelerated global expansion, technological scaling, and growing attention from investors and high-profile clients. From its inception, Good Look set...

Read more
Glidewell Opens Applications for the 2026 Guiding Leaders Program
Healthcare & PharmaceuticalConferences

Glidewell Opens Applications for the 2026 Guiding Leaders Program

January 8, 2026 12:00 PM

Applications are now open for the 2026 Guiding Leaders program, presented by Glidewell. Welcoming both men and women dentists, this six-month business and leadership development initiative runs from May through October at the Glidewell campus in Irvine, California. Entering its sixth year, this program delivers leadership, growth, and success skills for dentists at every career stage. Through a blend of advanced continuing education, one-on-one...

Read more
The Last Mile of Interoperability Is Still Manual for Behavioral Health and Post‑Acute Care
Healthcare & PharmaceuticalProduct Announcements

The Last Mile of Interoperability Is Still Manual for Behavioral Health and Post‑Acute Care

January 8, 2026 11:15 AM

A new Black Book® flash survey of 290 validated healthcare stakeholders finds that while interoperability headlines often emphasize national frameworks and HL7® FHIR® APIs, the "last mile" of cross-continuum exchange remains stubbornly manual for many organizations, especially across behavioral health, post-acute/long-term care, public health, and community-based organizations (CBOs). Respondents spanning health systems, behavioral health...

Read more
Curiosity Cub (TM) Completes 2025 Tour, Inspiring Future Innovators Through AI
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Curiosity Cub (TM) Completes 2025 Tour, Inspiring Future Innovators Through AI

January 8, 2026 11:00 AM

Each year, the Curiosity Cube™, a mobile science lab from MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, embarks on a mission to spark curiosity in STEM among students ages 8-13. In 2025, that mission expanded across three continents: the Curiosity Cube™ completed its seventh North American tour, its fourth European tour, and for the first time, brought hands on science to Southern Africa, stopping...

Read more
Aqua Sculpt Reviews: Breakthrough Hydro-Nutrient Complex Targets Deep Tissue Hydration and Metabolic Sculpting
Healthcare & PharmaceuticalCompany Update

Aqua Sculpt Reviews: Breakthrough Hydro-Nutrient Complex Targets Deep Tissue Hydration and Metabolic Sculpting

January 8, 2026 10:20 AM

Summary Aqua Sculpt has emerged as a significant topic of discussion within the wellness community, drawing attention for its unique approach to cellular hydration and metabolic support. An independent analysis of Aqua Sculpt reveals how its hydration-based formula is making waves. This report examines user complaints, verified reviews, and the science behind this non-stimulant weight loss supplement that is defining a new category in the 2025...

Read more
$50K Michael Jordan Jersey turns into a $4.5M Jackpot Discovery using Real Game Used's Patent Pending AI Technology
Healthcare & PharmaceuticalCompany Update

$50K Michael Jordan Jersey turns into a $4.5M Jackpot Discovery using Real Game Used's Patent Pending AI Technology

January 8, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its wholly owned subsidiary, Real Game Used (RGU), has identified what is believed to be a 1985-86 Chicago Bulls game-worn road jersey attributed to Michael Jordan through the company's patent-pending AI image-analysis and search technology. To the Company's knowledge, there are no other documented and conclusively photo-matched Michael Jordan jerseys from the 1985-86 NBA season...

Read more
NCQA Names Sarah E. Saxton as Senior Vice President of Quality Services
Healthcare & PharmaceuticalCompany Update

NCQA Names Sarah E. Saxton as Senior Vice President of Quality Services

January 8, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) today announced the appointment of Sarah E. Saxton, MBA, as Senior Vice President of Quality Services. Saxton brings more than 20 years of experience advancing quality, performance measurement, and large-scale transformation across public and private health systems. In this role, Saxton will lead NCQA's Quality Solutions Group, driving research and implementation efforts that underpin NCQA's...

Read more
Cellev8 Nutrition Welcomes Dr. Guangshuo
Healthcare & PharmaceuticalCompany Update

Cellev8 Nutrition Welcomes Dr. Guangshuo "Alan" Zhu, MD to Its Board of Directors

January 8, 2026 8:45 AM

Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant and cellular nutrition solutions, proudly announces the appointment of Dr. Guangshuo "Alan" Zhu, MD to its Board of Directors. Dr. Zhu brings decades of groundbreaking experience in cardiovascular medicine, translational research, and antioxidant biochemistry, including pioneering work in Superoxide Dismutase (SOD) - a core ingredient and biological inspiration...

Read more
Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines
Healthcare & PharmaceuticalConference Call

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

January 8, 2026 8:30 AM

Tivic Health® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that Management will host a special conference call to further discuss the company's recent acquisition of certain contract development and manufacturing organization (CDMO) assets as announced on December 11, 2025. The call will cover how the acquisition has accelerated key strategic priorities and development and commercialization timelines, as...

Read more
Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection
Healthcare & PharmaceuticalCompany Update

Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

January 8, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for novel therapeutics while reducing the potential for abuse and overdose, today announced it received a Notice of Allowance from the European Patent Office for the issuance of a patent* for PF8026, a groundbreaking Attention-Deficit/Hyperactivity Disorder (ADHD) therapy. PF8026 is a novel...

Read more
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy
Healthcare & PharmaceuticalCompany Update

Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy

January 8, 2026 7:00 AM

Ascend Advanced Therapies - ABL Inc. today announced significant appointments to its leadership team. Seiga Ohmine Ph.D. joins as Chief Commercial Officer (CCO) Sharad Dubey CA, CPA joins as Chief Financial Officer (CFO) Patrick Lansky joins as Senior Vice President of Global Business Development These appointments reflect Ascend-ABL's focus on strengthening scientific leadership, operational discipline, and customer-centric execution as the...

Read more
FDA Clears Toetal Solution's Ziptoe Hammertoe System
Healthcare & PharmaceuticalRegulatory

FDA Clears Toetal Solution's Ziptoe Hammertoe System

January 8, 2026 6:30 AM

Toetal Solution, Inc., a Runway Healthcare company, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Ziptoe™ Hammertoe System, an implant designed for proximal interphalangeal joint (PIPJ) arthrodesis in hammertoe correction procedures. The Ziptoe Hammertoe System was developed to deliver consistent fixation while supporting efficient, repeatable surgical workflow. Designed in collaboration with...

Read more
Neurodivergent Empowerment Institute Announces Open Artist Call for Activism-Based Art
Healthcare & PharmaceuticalDiversity, Equity and Inclusion

Neurodivergent Empowerment Institute Announces Open Artist Call for Activism-Based Art

January 8, 2026 6:00 AM

The Neurodivergent Empowerment Institute (NEI), part of the Bionic Bloom Wellness Collective family of wellness centers, is issuing an open call for artists creating activism-based art that challenges stigma, centers lived experience, and advocates for equity, autonomy, and human dignity. NEI is seeking artwork that does not remain neutral in the face of injustice. This call welcomes art that speaks directly to systems that impact...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?